# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-23-004757
Filing Date
2023-02-28
Accepted
2023-02-27 18:38:37
Documents
84
Period of Report
2022-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | acad-20221231.htm iXBRL | 10-K | 3994593
2 | EX-10.12 | acad-ex10_12.htm | EX-10 | 34264
3 | EX-10.33 | acad-ex10_33.htm | EX-10 | 828551
4 | EX-21.1 | acad-ex21_1.htm | EX-21 | 13702
5 | EX-23.1 | acad-ex23_1.htm | EX-23 | 13418
6 | EX-31.1 | acad-ex31_1.htm | EX-31 | 16008
7 | EX-31.2 | acad-ex31_2.htm | EX-31 | 16034
8 | EX-32.1 | acad-ex32_1.htm | EX-32 | 8813
9 | EX-32.2 | acad-ex32_2.htm | EX-32 | 8854
10 | GRAPHIC | img166113560_0.jpg | GRAPHIC | 22209
11 | GRAPHIC | img235382597_0.jpg | GRAPHIC | 182738
12 | GRAPHIC | img235382597_1.jpg | GRAPHIC | 33442
| Complete submission text file | 0000950170-23-004757.txt |  | 16635995

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
13 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | acad-20221231_def.xml | EX-101.DEF | 217519
14 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | acad-20221231.xsd | EX-101.SCH | 69547
15 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | acad-20221231_pre.xml | EX-101.PRE | 434637
16 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | acad-20221231_lab.xml | EX-101.LAB | 617599
17 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | acad-20221231_cal.xml | EX-101.CAL | 73430
78 | EXTRACTED XBRL INSTANCE DOCUMENT | acad-20221231_htm.xml | XML | 3622297

Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50768 | Film No.: 23677316
SIC: 2834 Pharmaceutical Preparations